SCHEMBL7672929

SCHEMBL7672929

CCC1=NN=C(c2ccccc2OC)[N]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.42
APP P05067 1/20 0.41
KDM4E B2RXH2 6/20 0.40
HPGD P15428 6/20 0.40
HSD17B10 Q99714 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA4 P22748 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
METAP2 P50579 1/20 0.38
HTR7 P34969 1/20 0.38
RAB9A P51151 3/20 0.38
NPC1 O15118 1/20 0.38
ALOX15 P16050 1/20 0.38
POLB P06746 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7682750 0.77 ALDH1A1 (0.46) ALDH1A1APPKDM4EHPGDHSD17B10
SCHEMBL29788337 0.69 CA1 (0.71) ALDH1A1APPKDM4EHPGDHSD17B10
SCHEMBL301996 0.69 CA1 (0.71) ALDH1A1APPKDM4EHPGDHSD17B10
SCHEMBL29429633 0.69 CA1 (0.71) ALDH1A1APPKDM4EHPGDHSD17B10
SCHEMBL14667558 0.67 HTR7 (0.49) ALDH1A1APPKDM4EHPGDHSD17B10
SCHEMBL29740506 0.66 CA1 (0.67) ALDH1A1APPKDM4EHPGDHSD17B10
SCHEMBL30599266 0.66 CA1 (0.67) ALDH1A1APPKDM4EHPGDHSD17B10
SCHEMBL11099503 0.66 CA1 (0.67) ALDH1A1APPKDM4EHPGDHSD17B10
SCHEMBL3643541 0.66 CA1 (0.67) ALDH1A1APPKDM4EHPGDHSD17B10
SCHEMBL12444265 0.65 RAB9A (0.58) ALDH1A1KDM4EHPGDHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US claimed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP claimed
JP-3110467-B2 2000-11-20 JP claimed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP claimed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO claimed
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed